Towards new antituberculotic targets: biochemical characterisation of mycobacterial RNase E/G Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007
Novel NTM treatments and approaches, repurposed to bacteriophages Source: Virtual Congress 2021 – New insights into nontuberculous mycobacteria disease: from diagnosis to treatment Year: 2021
T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation Source: Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018 Year: 2018
The use of the lytic D29 mycobacteriophages for accelerated determination of the drug sensitivity of tuberculosis mycobacteria to first and second-line anti-TB drugs in clinical isolates obtained after initial cultivation Source: Virtual Congress 2020 – Tuberculosis: part 2 Year: 2020
Comparative mycobacterial genomics as a tool for drug target and antigen discovery Source: Eur Respir J 2002; 20: 78S-86S Year: 2002
Genomics-based identification of targets in pathogenic bacteria for potential therapeutic use Source: Annual Congress 2004 - Novel approaches to the treatment of pneumonia Year: 2004
Design of immunogenic multiepitopic mycobacterium tuberculosis peptides from genes selected using in vitro models of mycobacterial macrophage infection Source: Eur Respir J 2007; 30: Suppl. 51, 493s Year: 2007
Immunological characterization of heparin binding hemagglutinin from mycobacterium tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Rapid diagnosis of pulmonary tuberculosis by combined molecular and immunological methods Source: Eur Respir J, 51 (5) 1702189; 10.1183/13993003.02189-2017 Year: 2018
SFTA3, a novel protein of the lung: three-dimensional structure, characterisation and immune activation Source: Eur Respir J 2014; 44: 447-456 Year: 2014
A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis Source: Eur Respir J 2015; 45: 1173-1176 Year: 2015
Characterisation of clinical phenotypes is mandatory for the development of new drugs Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
A proteomics approach for the identification of species-specific immunogenic proteins in the Mycobacterium abscessus complex Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019
Improved tracking of nosocomial transmission of multidrug resistant M. tuberculosis with a novel T cell-based test Source: Eur Respir J 2003; 22: Suppl. 45, 167s Year: 2003
Late Breaking Abstract - Anti-inflammatory activity of novel transtilbene sulfonamide analogues as potential novel therapeutic agents for inflammatory lung disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Quantitative membrane proteomics reveals new functions ofCD13 in mycobacterium tuberculosis infection Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
First experience with novel molecular diagnostic method for detection of M. tuberculosis and rifampicin resistance Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011